Evidence map›Paper›PMID 38507433›Full record

ArticlePloS one2024

Predicting hypertension control using machine learning.

Thomas Mroz, Michael Griffin, Richard Cartabuke, Luke Laffin, Giavanna Russo-Alvarez, George Thomas, Nicholas Smedira, Thad Meese, Michael Shost, Ghaith Habboub

Registry-linked trialAbstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07218198 (A Stepped Wedged, Cluster Randomized Clinical Trial to Evaluate the Efficacy of a Clinical Decision Support Tool in the Treatment of Uncontrolled Hypertension), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07218198 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

A Stepped Wedged, Cluster Randomized Clinical Trial to Evaluate the Efficacy of a Clinical Decision Support Tool in the Treatment of Uncontrolled Hypertension

TypeinterventionalSponsorThe Cleveland ClinicRan2026 to 2027Enrolled168ConditionsHypertension, Hypertension (HTN), Blood Pressure, High, Blood Pressure ControlArmsStandard medical treatment, Clinical Decision Support Tool
3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. The role of artificial intelligence in hypertension management.Current opinion in nephrology and hypertension · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Thomas MrozOrthopaedics and Rheumatology Institute, Cleveland Clinic, Cleveland, OH, United States of America.ORCID 0000-0002-3924-5043
Michael GriffinInsight Enterprises Inc., Chandler, AZ, United States of America.
Richard CartabukeDepartment of Internal Medicine, Cleveland Clinic, Cleveland, OH, United States of America.
Luke LaffinDepartment of Cardiovascular Medicine, Center for Blood Pressure Disorders, Cleveland Clinic, Cleveland, OH, United States of America.
Giavanna Russo-AlvarezDepartment of Hospital Outpatient Pharmacy, Cleveland Clinic, Cleveland, OH, United States of America.
George ThomasDepartment of Kidney Medicine, Cleveland Clinic, Cleveland, OH, United States of America.
Nicholas SmediraDepartment of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH, United States of America.
Thad MeeseDepartment of Innovations Technology Development, Cleveland Clinic, Cleveland, OH, United States of America.
Michael ShostCenter for Spine Health, Cleveland Clinic, Cleveland, OH, United States of America.ORCID 0000-0003-1833-0342
Ghaith HabboubCenter for Spine Health, Cleveland Clinic, Cleveland, OH, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension is a widely prevalent disease and uncontrolled hypertension predisposes affected individuals to severe adverse effects. Though the importance of controlling hypertension is clear, the multitude of therapeutic regimens and patient factors that affect the success of blood pressure control makes it difficult to predict the likelihood to predict whether a patient's blood pressure will be controlled. This project endeavors to investigate whether machine learning can accurately predict the control of a patient's hypertension within 12 months of a clinical encounter. To build the machine learning model, a retrospective review of the electronic medical records of 350,008 patients 18 years of age and older between January 1, 2015 and June 1, 2022 was performed to form model training and testing cohorts. The data included in the model included medication combinations, patient laboratory values, vital sign measurements, comorbidities, healthcare encounters, and demographic information. The mean age of the patient population was 65.6 years with 161,283 (46.1%) men and 275,001 (78.6%) white. A sliding time window of data was used to both prohibit data leakage from training sets to test sets and to maximize model performance. This sliding window resulted in using the study data to create 287 predictive models each using 2 years of training data and one week of testing data for a total study duration of five and a half years. Model performance was combined across all models. The primary outcome, prediction of blood pressure control within 12 months demonstrated an area under the curve of 0.76 (95% confidence interval; 0.75-0.76), sensitivity of 61.52% (61.0-62.03%), specificity of 75.69% (75.25-76.13%), positive predictive value of 67.75% (67.51-67.99%), and negative predictive value of 70.49% (70.32-70.66%). An AUC of 0.756 is considered to be moderately good for machine learning models. While the accuracy of this model is promising, it is impossible to state with certainty the clinical relevancy of any clinical support ML model without deploying it in a clinical setting and studying its impact on health outcomes. By also incorporating uncertainty analysis for every prediction, the authors believe that this approach offers the best-known solution to predicting hypertension control and that machine learning may be able to improve the accuracy of hypertension control predictions using patient information already available in the electronic health record. This method can serve as a foundation with further research to strengthen the model accuracy and to help determine clinical relevance.

Indexed as

HypertensionMachine LearningAdolescentAdultAgedComorbidityFemaleHumansMalePredictive Value of TestsRetrospective Studies

Identifiers

PMID38507433
PMCPMC10954144

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.